Posted inEuronext
Biophytis SA narrows losses but warns of cash shortfall beyond September 2025
PARIS: Clinical-stage biotech Biophytis SA (Euronext Growth: ALBPS) reported significantly reduced losses for 2024 and outlined ambitious clinical plans for obesity and sarcopenia treatments, while flagging a critical funding gap…